TG Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
19.04.24
/
50%
€12.95
Target price
19.04.25
€23.48
Performance (%)
13.50%
Price
12:04
€14.70
Summary
This prediction is currently active. The prediction currently has a performance of 13.50%. This prediction currently runs until 19.04.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| TG Therapeutics Inc. | -2.187% |
| iShares Core DAX® | -0.992% |
| iShares Nasdaq 100 | -0.225% |
| iShares Nikkei 225® | -0.736% |
| iShares S&P 500 | -0.509% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $25.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat